NCT07073521

Brief Summary

The goal of this study is to develop and pilot test a therapeutic strategy combining cognitive behavioral therapy (CBT) with mindfulness practices tailored for individuals adjusting to vision loss. The study will begin with focus groups to inform the design of the intervention. Participants will complete brief surveys on their background and experiences with vision loss prior to attending a focus group, and some may be invited to a second session to provide additional feedback before preliminary testing begins. In the pilot phase, participants will attend weekly group therapy sessions using the developed intervention and complete assessments before and after the program, including questions about vision status, demographics, and experiences with vision loss.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
14mo left

Started Jul 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jul 2025Jul 2027

First Submitted

Initial submission to the registry

July 10, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

July 14, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2027

Last Updated

July 30, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

July 10, 2025

Last Update Submit

July 25, 2025

Conditions

Keywords

Visually impairedBlindVision lossmental healthCBTCognitive-behavioral therapy (CBT)mindfulnessadjustment to vision lossfocus grouppilot testgroup therapy

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Mean Adaption to Vision Loss (AVL) Scale Score

    The AVL is a 24-item self-report questionnaire rated on a 5-point Likert scale. Items assess emotional and psychosocial adjustment to vision loss. Scores range from 1 to 5, with higher scores indicating better adaptation. Some items are reverse-scored.

    Assessed at baseline and following the 8-week intervention period

Secondary Outcomes (2)

  • Change from Baseline in Mean Patient Health Questionnaire (PHQ-9) Score

    Assessed at baseline and following the 8-week intervention period

  • Change from Baseline in Mean Generalized Anxiety Disorder (GAD-7) Score

    Assessed at baseline and following the 8-week intervention period

Study Arms (1)

Pilot Testing - Assessing Feasibility and Acceptability

EXPERIMENTAL

Participants will be testing an 8-week therapeutic strategy combining cognitive behavioral therapy (CBT) with mindfulness practices tailored for people adjusting to vision loss in a group therapy setting and complete assessments before and after completing the program.

Behavioral: Integrated Cognitive Behavioral Therapy (CBT) & Mindfulness Group Intervention for Adjustment to Vision Loss

Interventions

The intervention will be an 8-week integrated group therapy curriculum combining cognitive behavioral therapy (CBT) with mindfulness practices designed for individuals adjusting to vision loss.

Pilot Testing - Assessing Feasibility and Acceptability

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults who are at least 18 years old
  • Experiencing varying degrees of vision loss (e.g. mild, moderate, severe)
  • Willingness to participate in the focus group or pilot testing and provide feedback

You may not qualify if:

  • Individuals with severe cognitive impairment affecting participation
  • Congenital blindness
  • Recent or current participation in another clinical trial study or medical intervention that may interfere with study results
  • Documented or self-reported health condition that may interfere with the outcomes of this study.
  • Deemed unfit to participate in the study by the site investigator
  • Unwilling and/or unable to participate or provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chicago Lighthouse

Chicago, Illinois, 60608, United States

RECRUITING

MeSH Terms

Conditions

DepressionAnxiety DisordersVision DisordersBlindnessVision, LowPsychological Well-Being

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPersonal Satisfaction

Study Officials

  • Chief Research Officer

    The Chicago Lighthouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Senior Research Associate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Research Officer

Study Record Dates

First Submitted

July 10, 2025

First Posted

July 18, 2025

Study Start

July 14, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 13, 2027

Last Updated

July 30, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations